Lava Therapeutics NV 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
LAVA Therapeutics, a clinical-stage immuno-oncology company, announces its 2024 financial results and a strategic review aimed at extending capital resources.